goserelin 3.6 mg injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for goserelin 3.6 mg injection, covering 2025-02-17 to 2025-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer [Phase 3]